92 related articles for article (PubMed ID: 31274515)
1. Expression Analysis of RbBP6 in human cancers: a Prospective biomarker.
Mbita Z; Hull R; Mbele M; Makhafola T; Dlamini Z
Anticancer Drugs; 2019 Sep; 30(8):767-773. PubMed ID: 31274515
[TBL] [Abstract][Full Text] [Related]
2. De-regulation of the RBBP6 isoform 3/DWNN in human cancers.
Mbita Z; Meyer M; Skepu A; Hosie M; Rees J; Dlamini Z
Mol Cell Biochem; 2012 Mar; 362(1-2):249-62. PubMed ID: 22139301
[TBL] [Abstract][Full Text] [Related]
3. DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitin-like pathways.
Pugh DJ; Ab E; Faro A; Lutya PT; Hoffmann E; Rees DJ
BMC Struct Biol; 2006 Jan; 6():1. PubMed ID: 16396680
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis and association of RBBP6 with apoptosis in colon cancers.
Dlamini Z; Rupnarain C; Naicker S; Hull R; Mbita Z
J Mol Histol; 2016 Apr; 47(2):169-82. PubMed ID: 26905308
[TBL] [Abstract][Full Text] [Related]
5. Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises breast cancer cells MCF7 to staurosporine and camptothecin-induced cell death.
Moela P; Choene MM; Motadi LR
Immunobiology; 2014 Aug; 219(8):593-601. PubMed ID: 24703106
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer.
Motadi LR; Bhoola KD; Dlamini Z
Immunobiology; 2011 Oct; 216(10):1065-73. PubMed ID: 21676486
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and characterisation of the p53 binding domain of Retinoblastoma binding protein 6 (RBBP6).
Russell BL; Ntwasa M
PLoS One; 2023; 18(2):e0277478. PubMed ID: 36763571
[TBL] [Abstract][Full Text] [Related]
8. RBBP6 isoforms regulate the human polyadenylation machinery and modulate expression of mRNAs with AU-rich 3' UTRs.
Di Giammartino DC; Li W; Ogami K; Yashinskie JJ; Hoque M; Tian B; Manley JL
Genes Dev; 2014 Oct; 28(20):2248-60. PubMed ID: 25319826
[TBL] [Abstract][Full Text] [Related]
9. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer.
Xiao C; Wu G; Zhou Z; Zhang X; Wang Y; Song G; Ding E; Sun X; Zhong L; Li S; Weng J; Zhu Z; Chen J; Wang X
Cell Death Dis; 2019 Nov; 10(11):833. PubMed ID: 31685801
[TBL] [Abstract][Full Text] [Related]
10. RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1.
Chibi M; Meyer M; Skepu A; G Rees DJ; Moolman-Smook JC; Pugh DJ
J Mol Biol; 2008 Dec; 384(4):908-16. PubMed ID: 18851979
[TBL] [Abstract][Full Text] [Related]
11. RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression.
Dlamini Z; Ledwaba T; Hull R; Naicker S; Mbita Z
Biomark Cancer; 2019; 11():1179299X19829149. PubMed ID: 30886526
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of RING finger-like domain of retinoblastoma-binding protein-6 (RBBP6) suggests it functions as a U-box.
Kappo MA; Ab E; Hassem F; Atkinson RA; Faro A; Muleya V; Mulaudzi T; Poole JO; McKenzie JM; Chibi M; Moolman-Smook JC; Rees DJ; Pugh DJ
J Biol Chem; 2012 Mar; 287(10):7146-58. PubMed ID: 22130672
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.
Chen J; Tang H; Wu Z; Zhou C; Jiang T; Xue Y; Huang G; Yan D; Peng Z
PLoS One; 2013; 8(6):e66524. PubMed ID: 23799110
[TBL] [Abstract][Full Text] [Related]
14. RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
Xiao C; Wang Y; Zheng M; Chen J; Song G; Zhou Z; Zhou C; Sun X; Zhong L; Ding E; Zhang Y; Yang L; Wu G; Xu S; Zhang H; Wang X
Cancer Sci; 2018 Apr; 109(4):1075-1087. PubMed ID: 29369481
[TBL] [Abstract][Full Text] [Related]
15. RBBP6 expressional effects on cell proliferation and apoptosis in breast cancer cell lines with distinct p53 statuses.
Motadi LR; Lekganyane MM; Moela P
Cancer Manag Res; 2018; 10():3357-3369. PubMed ID: 30237738
[TBL] [Abstract][Full Text] [Related]
16. RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines.
Moela P; Motadi LR
Onco Targets Ther; 2016; 9():4721-35. PubMed ID: 27536134
[TBL] [Abstract][Full Text] [Related]
17. RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6.
Liu YJ; Cui LL; Liu ZS; Jia RY; Ding YX; Xu LZ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10366-10374. PubMed ID: 33155192
[TBL] [Abstract][Full Text] [Related]
18. RBBP6 promotes human cervical carcinoma malignancy via JNK signaling pathway.
Teng F; Ruan HJ; Xu J; Ni J; Qian B; Shen R; Gao LJ
Biomed Pharmacother; 2018 May; 101():399-405. PubMed ID: 29501043
[TBL] [Abstract][Full Text] [Related]
19. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
20. The association of RBBP6 variant 3 expressions with apoptosis in human immunodeficiency virus-associated nephropathy (HIVAN).
Mbita Z; Naicker S; Goetsch S; Dlamini Z
Exp Mol Pathol; 2015 Aug; 99(1):74-80. PubMed ID: 25910411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
